2022
Nucleic Acid Delivery to the Vascular Endothelium
Reschke M, Piotrowski-Daspit AS, Pober JS, Saltzman WM. Nucleic Acid Delivery to the Vascular Endothelium. Molecular Pharmaceutics 2022, 19: 4466-4486. PMID: 36251765, PMCID: PMC10673694, DOI: 10.1021/acs.molpharmaceut.2c00653.Peer-Reviewed Original ResearchWanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs
Liburd ST, Shi AA, Pober JS, Tietjen GT. Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs. American Journal Of Transplantation 2022, 22: 1754-1759. PMID: 35373446, PMCID: PMC9651180, DOI: 10.1111/ajt.17050.Peer-Reviewed Original ResearchConceptsNormothermic machine perfusionEndothelial cellsGraft vasculaturePoor outcomePreservation injuryMachine perfusionProfound shortageOrgan assessmentTransplant therapeuticsDonor comorbiditiesAllograft organClinical useOrgansAttractive targetNanotherapeutic deliveryTherapeutic vehiclesCellsTherapeutic deliveryDeliveryComorbiditiesTransplantGraftInjuryPerfusionVasculature
2011
Cellular Delivery for Vascularization of Engineered Tissues: Reduction of Contraction by Mural Cells
Andrejecsk J, Trivellas M, Maier C, Pober J, Saltzman W. Cellular Delivery for Vascularization of Engineered Tissues: Reduction of Contraction by Mural Cells. 2011, 1: 1-2. DOI: 10.1109/nebc.2011.5778700.Peer-Reviewed Original ResearchEndothelial cellsReduction of contractionHuman endothelial cellsImmunodeficient miceHuman pericytesEarly perfusionGel contractionMural cellsVascular structuresVascular stabilityPericytesMicrovesselsTissueVascular networkVascularizationCellsContractionFunctional vascular networkDeliverySimultaneous deliveryTransplantationPerfusionMice